Brazil vs Europe: Proportion of the target population who received the final dose of
Brazil
79.0%
in 2024
Europe
40.0%
in 2024
Brazil rank
24th
Europe rank
21st
Proportion of the target population who received the final dose of over time
- Brazil
- Europe
How they compare
Brazil currently reports 79.0% against 40.0% in Europe, a difference of 39.0%.
That makes Brazil's figure about 2.0 times Europe's.
Across all 11 years both countries report, Brazil has been ahead every year.
Brazil ranks 24th and Europe ranks 21st of 107 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Europe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 68.7% | 32.5% | 36.2% | Brazil |
| 2020s | 73.2% | 36.8% | 36.4% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Brazil or Europe?
- Brazil, at 79.0% against 40.0% in Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Brazil and Europe?
- 39.0%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Europe?
- 11 years are reported by both, from 2014 to 2024.
- How do Brazil and Europe rank globally for proportion of the target population who received the final dose of?
- Brazil ranks 24th and Europe ranks 21st of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.